Cardlytics Inc [NASDAQ: CDLX] jumped around 1.33 points on Thursday, while shares priced at $2.76 at the close of the session, up 92.66%.
Compared to the average trading volume of 1.66M shares, CDLX reached a trading volume of 122758174 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Cardlytics Inc [CDLX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CDLX shares is $1.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CDLX stock is a recommendation set at 3.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Cardlytics Inc shares, keeping their opinion on the stock as In-line, with their previous recommendation back on October 11, 2024. The new note on the price target was released on August 16, 2024, representing the official price target for Cardlytics Inc stock. Previously, the target price had yet another drop from $4 to $3.50, while BofA Securities kept a Underperform rating on CDLX stock.
The Price to Book ratio for the last quarter was 2.49, with the Price to Cash per share for the same quarter was set at 0.88.
How has CDLX stock performed recently?
Cardlytics Inc [CDLX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 139.57. With this latest performance, CDLX shares gained by 150.45% in over the last four-week period, additionally plugging by 20.83% over the last 6 months – not to mention a drop of -25.74% in the past year of trading.
Cardlytics Inc [CDLX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Cardlytics Inc [CDLX] shares currently have an operating margin of -21.41% and a Gross Margin at 45.16%. Cardlytics Inc’s Net Margin is presently recorded at -68.87%.
Cardlytics Inc (CDLX) Capital Structure & Debt Analysis
According to recent financial data for Cardlytics Inc. ( CDLX), the Return on Equity (ROE) stands at -136.44%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -40.95%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Cardlytics Inc’s Return on Invested Capital (ROIC) is -79.05%, showcasing its effectiveness in deploying capital for earnings.
Cardlytics Inc (CDLX) Efficiency & Liquidity Metrics
Based on Cardlytics Inc’s (CDLX) latest financial statements, the Debt-to-Equity Ratio is 3.75%, indicating its reliance on debt financing relative to shareholder equity.
Cardlytics Inc (CDLX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Cardlytics Inc. (CDLX) effectively leverages its workforce, generating an average of -$403832.6 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.16% and a Quick Ratio of 1.16%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Cardlytics Inc [CDLX]
With the latest financial reports released by the company, Cardlytics Inc posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.12. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CDLX.
Insider trade positions for Cardlytics Inc [CDLX]
There are presently around $45.79%, or 47.18%% of CDLX stock, in the hands of institutional investors. The top three institutional holders of CDLX stocks are: CAS INVESTMENT PARTNERS, LLC with ownership of 6.46 million shares, which is approximately 13.1785%. BLACKROCK INC., holding 3.15 million shares of the stock with an approximate value of $$25.88 million in CDLX stocks shares; and BLACKROCK INC., currently with $$19.81 million in CDLX stock with ownership which is approximately 4.9179%.
